The capability of ghrelin to limit apoptosis of endothelial cells and cardiomyocytes in vitro introduces the possibility of reducing endothelial dysfunction associated with atherosclerotic risk [476–478] and salvaging myocardium in zones of marginal chemotoxicity [479] or ischemia [22, 194, 461, 480]. Here, GHRL is linked to ischemia.